Medicina
Facultad
St. James's Hospital
Dublín, IrlandaPublicaciones en colaboración con investigadores/as de St. James's Hospital (19)
2024
-
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322
2023
-
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376
-
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients
British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876
2022
-
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
The Lancet Oncology, Vol. 23, Núm. 8, pp. e374-e384
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
2021
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749
2018
-
Establishing the European diagnostic reference levels for interventional cardiology
Physica Medica, Vol. 54, pp. 42-48
2012
-
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: Analysis of data from the phase 3 FLEX study
The Lancet Oncology, Vol. 13, Núm. 1, pp. 33-42
-
Treatment rationale study design for the MetLung trial: A randomized, double-blind phase III study of onartuzumab (MetMAb) in combination with erlotinib versus erlotinib alone in patients who have received standard chemotherapy for stage IIIB or IV met-positive non-small-cell lung cancer
Clinical Lung Cancer, Vol. 13, Núm. 6, pp. 500-504
2011
-
First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: A subgroup analysis of data from the FLEX phase 3 study
The Lancet Oncology, Vol. 12, Núm. 1, pp. 30-37
-
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
The Lancet Oncology, Vol. 12, Núm. 8, pp. 795-805
2008
-
QA/acceptance testing of DEXA X-ray systems used in bone mineral densitometry
Radiation Protection Dosimetry, Vol. 129, Núm. 1-3, pp. 279-283
2006
-
Discussion
Round Table Series - Royal Society of Medicine
-
Discussion
Round Table Series - Royal Society of Medicine
-
Discussion
Round Table Series - Royal Society of Medicine
1993
-
The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
New England Journal of Medicine, Vol. 329, Núm. 22, pp. 1615-1622